MUCOSAL HEALING WITH VEDOLIZUMAB IN INFLAMMATORY BOWEL DISEASE: EVIDENCE FROM EARNEST, A RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED TRIAL IN CHRONIC POUCHITIS
Vipul Jairath 1
Brian G. Feagan 2
Mark S. Silverberg 3
Silvio Danese 4
Paolo Gionchetti 5
Mark Lowenberg 6
Brian Bressler 7
Marc Ferrante 8
Ailsa L Hart 9
Dirk Lindner 10
Armella Escher 10
Stephen Jones 10
Bo Shen 11
Simon Travis 12
1 Western University, London, Canada
2 Alimentiv Inc., London, Canada
3 Mount Sinai Hospital, Toronto, Canada
4 Vita-Salute San Raffaele University - IRCCS San Raffaele Scientific Institute, Milan, Italy
5 IRCCS Azienda Ospedaliera-Universitaria di Bologna University of Bologna, Bologna, Italy
6 Amsterdam University Medical Center, Amsterdam, Netherlands
7 University of British Columbia, Vancouver, Canada
8 University Hospitals Leuven, Leuven, Belgium
9 St Mark’s Hospital and and Imperial College London, London, United Kingdom
10 Takeda Pharmaceuticals International AG, Zurich, Switzerland
11 Columbia University Irving Medical Center/Herbert Irving Pavilion, New York, United States
12 John Radcliffe Hospital, Oxford, United Kingdom
Session
Clinical trials in IBD (Posters)
Conference
UEG Week 2022
Citation
United European Gastroenterology Journal 2022; 10 (Supplement 8)
Login to access library content
Do you need help setting up your myUEG account?
Contact us at [email protected]